Improving quality of life for patients with hypersensitivity pneumonitis
Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis
This study is testing a new support program that uses peer coaching to help people with hypersensitivity pneumonitis feel better and understand their condition more clearly.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Weill Medical College of Cornell University Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT06811389 on ClinicalTrials.gov |
What this trial studies
This intervention focuses on enhancing the health-related quality of life (HRQOL) for patients diagnosed with hypersensitivity pneumonitis through a peer coach-delivered program. The RISE-HP intervention combines cognitive behavioral principles with targeted patient education over ten sessions. It aims to address the emotional and informational needs of patients, who often experience anxiety and a lack of understanding about their condition. The study will assess the feasibility and accessibility of this innovative approach to patient support.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with a documented diagnosis of hypersensitivity pneumonitis who are English-speaking and have access to a smartphone or tablet.
Not a fit: Patients with severe cognitive impairment or those experiencing severe depression may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the quality of life for patients suffering from hypersensitivity pneumonitis.
How similar studies have performed: While this approach is innovative, similar interventions targeting quality of life improvements in chronic conditions have shown promise in other studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have documented diagnosis of Hypersensitivity Pneumonitis by treating clinician. * Age 18 or older. * English Speaking. * Willing to work with a peer coach. * Have a working smart phone or tablet. * Have access to the internet. * Reside or live in the United States. * Endorse verbal approval from treating physician to participate in patients' goal movement/physical activity. * Meet one or more of the following criteria: * Baseline score on the PHQ8 of \<20 Exclusion Criteria: * Does not have Hypersensitivity Pneumonitis * Younger than age 18 * Severe cognitive impairment as determined by their treating physician. * Participants with severe depression (PHQ-8 score ≥20) will be ineligible for the study and will be referred to alternative sources of care. * Anyone with documentation in their medical chart of an eating disorder, active substance use disorder, suicidality, homicidality, acute posttraumatic stress disorder, or episodes of mania or psychosis. * Anyone who is determined to be severely ill or moribund by the treating clinician.
Where this trial is running
New York, New York
- Weill Cornell Medicine — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Kerri I Aronson, MD — Weill Medical College of Cornell University
- Study coordinator: Anna Tharakan, BS
- Email: ant4034@med.cornell.edu
- Phone: (646)962-8130
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.